Presentation by Adrian Flowerday, Managing Director, Docobo at the Big Innovation Conversation: Operational excellence webinar on Thursday 11 October 2018.
A lot of dentists are still hesitant to make a move towards the digitalization of their clinical practice. However, the increasing importance and use of teledentistry is encouraging and shows a lot of promise to develop the field of dentistry. It has shown a significant use in networking, consultations, dental records sharing, and aiding in para clinical procedures.
This information sheet provides an overview of a number of ways in which we collect, analyse and publish national data and statistics.
Our information services and products are used by a range of organisations to support the commissioning and delivery of services, for research and academic studies, and to provide targeted information to patients, service users and the public.
Every year millions of outpatient hospital appointments are
missed, with many doctors stating that a significant fraction
of these are down to navigational issues.1
It isn’t just visitors that are affected by wayfinding either.
Staff are also expected to navigate with ease around the
workplace and the ramifications can be much more serious
then a missed appointment.
A lot of dentists are still hesitant to make a move towards the digitalization of their clinical practice. However, the increasing importance and use of teledentistry is encouraging and shows a lot of promise to develop the field of dentistry. It has shown a significant use in networking, consultations, dental records sharing, and aiding in para clinical procedures.
This information sheet provides an overview of a number of ways in which we collect, analyse and publish national data and statistics.
Our information services and products are used by a range of organisations to support the commissioning and delivery of services, for research and academic studies, and to provide targeted information to patients, service users and the public.
Every year millions of outpatient hospital appointments are
missed, with many doctors stating that a significant fraction
of these are down to navigational issues.1
It isn’t just visitors that are affected by wayfinding either.
Staff are also expected to navigate with ease around the
workplace and the ramifications can be much more serious
then a missed appointment.
Rob Halhead - ECO 17: Transforming care through digital healthInnovation Agency
Presentation by Rob Halhead, COO, Docobo: Enabling transformation at ECO 17: Transforming care through digital health on Tuesday 4 December at Lancaster University, Lancaster
eHealth as a tool to support health practitioners November 2013Rajeev Rao Eashwari
“Telemedicine begins with a vision of connecting people to people, connecting resources to needs, and connecting healthcare problems to health care solutions”
mHealth Israel_Hospitals and Healthcare Data_Carol Gomes_Stony Brook Universi...Levi Shapiro
Presentation by Carol Gomes, CEO / COO, Stony Brook University Hospital: Hospitals + Healthcare Data. Key Sections:
- Overview of Stony Brook Medicine Health System
- IT capital planning process
- Transition from Fee-for-Service
- Clinically Integrated Network
- Population Health Analytics Platform
- REGISTRIES – Benchmarking Quality
- Digital Transformation- Business & Clinical Capacity
- Transformation Projects: Analytics; Real-Time Health System Capabilities; Telehealth Services; Command Center Capabilities
- Command Center: Centralized Throughput Office (CTO)
- Command Throughput Office Dashboard
- Real-Time Dashboards
- Early Progress of Command Throughput Office (Boarders, Cases)
- Mobile STROKE Unit Program
- Telemedicine / TeleHealth
- Stony Brook University Hospital awarded $966,026
- Data Strategy in Decentralized Environment
- Call to Action for Startups
apidays LIVE India - The digitisation of healthcare by Dr S.S. Lal, Global Fo...apidays
apidays LIVE India 2021 - Connecting 1.3 billion digital innovators
May 20, 2021
The digitisation of healthcare
Dr S.S. Lal, President of Global Foundation for Health and Hygiene
Speakers' slides at the Wessex MedTech Event 2018 titled: Supporting Innovation in Medical Technology Enterprises.
Hosted by the Wessex AHSN and NIHR CRN Wessex, in partnership with the NIHR SME roadshow.
Presentations by Tawfiq Choudhury and Rocco Hadland from the second webinar of the Mastering Cholesterol webinar series on Thursday 11 May 2023, focusing on Statins.
Targeting lipids: a primary and secondary care perspectiveInnovation Agency
Presentations by Dr Sue Kemsley and Dr Gavin Galasko from the first webinar of the Mastering Cholesterol webinar series on Thursday 26 January 2023, focusing on lipid management from a primary and secondary care perspective.
Supporting the optimal detection and management of BP in Primary CareInnovation Agency
Presentation by Jane Briers, Programme Manager - Innovation Agency at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Presentation by Dr Lauren Moorcroft, GP Partner - Brookvale Practice at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Introduction to Supporting recovery in Primary Care using Proactive Framework...Innovation Agency
Presentation by Julia Reynolds, Associate Director for Transformation - Innovation Agency at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Presentation by Paul Brain, Project Manager at the Excel in Health series - Introduction to data webinar on Monday 6 June 2022.
In this session we discussed how SMEs can use data to grow their business and access new opportunities in the market.
Presentations by Mike Kenny, Acting Co-Director of Enterprise and Growth, Innovation Agency and Dr Neil Paul, a GP and Board Member with Cheshire East ICP at the Excel in Health: Understanding the NHS Landscape webinar on Wednesday 11 May 2022.
LCR and Cheshire and Merseyside Health MATTERS networking eventInnovation Agency
Master slide deck from the LCR and Cheshire and Merseyside Health MATTERS networking event on Wednesday 24 November 2021 at Sci-Tech Daresbury Laboratory.
Master slide deck from the Excel in Health webinar series: The NHS landscape presentation.
This webinar identifies the structure of the NHS and its national priorities.
The session will cover the following topics:
Understand the structure of the NHS
Understand the national priorities of the NHS
Recognise the barriers to sale
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYNEHA GUPTA
The process of drug discovery and development is a complex and multi-step endeavor aimed at bringing new pharmaceutical drugs to market. It begins with identifying and validating a biological target, such as a protein, gene, or RNA, that is associated with a disease. This step involves understanding the target's role in the disease and confirming that modulating it can have therapeutic effects. The next stage, hit identification, employs high-throughput screening (HTS) and other methods to find compounds that interact with the target. Computational techniques may also be used to identify potential hits from large compound libraries.
Following hit identification, the hits are optimized to improve their efficacy, selectivity, and pharmacokinetic properties, resulting in lead compounds. These leads undergo further refinement to enhance their potency, reduce toxicity, and improve drug-like characteristics, creating drug candidates suitable for preclinical testing. In the preclinical development phase, drug candidates are tested in vitro (in cell cultures) and in vivo (in animal models) to evaluate their safety, efficacy, pharmacokinetics, and pharmacodynamics. Toxicology studies are conducted to assess potential risks.
Before clinical trials can begin, an Investigational New Drug (IND) application must be submitted to regulatory authorities. This application includes data from preclinical studies and plans for clinical trials. Clinical development involves human trials in three phases: Phase I tests the drug's safety and dosage in a small group of healthy volunteers, Phase II assesses the drug's efficacy and side effects in a larger group of patients with the target disease, and Phase III confirms the drug's efficacy and monitors adverse reactions in a large population, often compared to existing treatments.
After successful clinical trials, a New Drug Application (NDA) is submitted to regulatory authorities for approval, including all data from preclinical and clinical studies, as well as proposed labeling and manufacturing information. Regulatory authorities then review the NDA to ensure the drug is safe, effective, and of high quality, potentially requiring additional studies. Finally, after a drug is approved and marketed, it undergoes post-marketing surveillance, which includes continuous monitoring for long-term safety and effectiveness, pharmacovigilance, and reporting of any adverse effects.
Tests for analysis of different pharmaceutical.pptx
Adrian Flowerday - Big Innovation Conversation: Operational excellence
1. Improving operational excellence
with Digital Health solutions
Adrian Flowerday
Adrian Flowerday CEng NHS Innovation Accelerator (NIA) Fellow
DOCOBO Limited
Adrian.flowerday@docobo.co.uk
@DocoboUK
3. Docobo Digital Health Platform
Remote patient recorded data
Secure, Robust, Regulatory compliant Digital Health platform
The Radar for Health
and Social Care
Data from Hospital, GP,
Community, Mental, Social,
Ambulance
Enables data driven
decisions and delivery
DOC@HOME
Identify & track patients
(Costs, Risks, Trends)
Observe
Intervene
ARTEMUS-ICS
Various Patient Interaction Options
• Patient Need
• Technical and Cognitive Ability
• Cost
4. • Population Stratification
• Cohort Analysis
• Patient Overview
Multi-layers of population and patient information
ARTEMUSICS™ Technical Introduction
10. Has my intervention made a difference?
ArtemusICS - Powerful before/after evaluation capability
Up to 365 days before Up to 365 days after
11. Population
Cohort
Individual
Data from Acute, GP,
Community, Mental, Social,
Ambulance
• Predictive analytical tools
• Rich filtering capability by
conditions, cost, age,
utilisation, etc
• Identification of utilisation,
prevalence and costs
• Identify intervention cohorts
• Identify gaps in care
• Identify integrated care
needs of individuals
• Support cradle to grave
Enables integrated, care
co-ordination across
sectors
• Tracks outcomes and RoI
• Enables automated
commissioning
In use with: Crawley and Horsham CCG’s
Surrey downs CCG
Liverpool CCG
Cornwall GP federations
ArtemusICS – Population
Health Intelligence
Frances Tippett, NHSE SW quoted:
“There is nothing that goes into such
detail for both commissioners and
providers”
12. Opportunities for operational excellence
1. ArtemusICS Population Health:
• Reduced staff time to find intelligence - data, cohorts, performance,
prevalence, gaps in care, costs, etc - 30-40% staff reduction
• Focus resources only on areas of need, not across a whole geography
• Identify the right patients for the right interventions – improve ROI
• Medicines optimisation
2. doc@HOME Remote Monitoring:
• Community teams visit only by exception – increased caseload
• Reduced 999 conveyancing
• Reduced A&E attendances/admissions
• Virtual Outpatients
• Reduced length of stay
13. 13
Docobo Limited
21 High Street, Bookham, Surrey. KT23 4AA
info@docobo.co.uk
+1372 459 866
To find out more about improving effiencies through Digital Health
contact: adrian.flowerday@docobo.co.uk
THANK YOU
Improving Operational Efficiencies ...
…with Population Health Intelligence and Remote Monitoring